Figure 6 Together, proteomic and phosphoproteomic profiling highlighted cell cycle and proliferation pathways as key targets of the double and triple drug combinations ( Figures 6C, D
Additionally, large-scale commercial development was eventually discontinued
As a certified national high-tech enterprise, we speciaize in end-to-end services encompassing pharmaceutical active ingredients(apis), advanced intermediates, bioactive compounds, peptide therapeutics, veterinary pharmaceuticals, and speciaty chemical reagents, while pioneeringbreakthrouohs in cosmetic functional ingredients and novel health materials Core competencies: Leveraging an 1s0 9001: 2015-certified quaity management system and state-of-the-ar R&D facilities, we deliver quadripartite competitive advantagesInnovative R&D: 0perates bsl-2 laboratories and kilogram-scale GMP pilot plants, supported by a pH
Step 6: Remove the syringe
Take the first step towards a healthier, happier you